After achieving a landmark settlement, in which the negligent defendants have agreed to fund immunotherapy for a claimant who has developed cancer, Michael Rawlinson QC examines the dilemma of the prospect and effect of immunotherapy in a recent blog post.
The full blog post can be found here.
Breakfast briefing: Delivering an effective online mediation
© Copyright 2020 Kings Chambers. All rights reserved.
Continue using site